Stocks To Track: CONSOL Energy Inc. (CNX), CVS Health Corporation (CVS), MannKind Corporation (MNKD)

CONSOL Energy Inc. (CNX) fell -4.5% during last trading as the stock lost $-0.82 to finish the day at $17.41 with about 5.94M shares changing hands, compared to its three month average trading volume of 4.04M. The $4.1B market cap company, which fluctuated between $17.02 and $18.57 during the day, currently situated 284.01% above its 52 week low of $4.54 and -22.07% away from its one year high of $22.34. The RSI of 33.88 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CONSOL Energy Inc., together with its subsidiaries, operates as an integrated energy company in the United States and internationally. The company operates through two divisions, Exploration and Production (E&P), and Coal. The E&P division produces pipeline quality natural gas primarily to gas wholesalers. This division owns rights to extract natural gas in Pennsylvania, West Virginia, and Ohio from approximately 436,000 net Marcellus Shale acres; and controls approximately 119,000 net acres of Utica Shale potential in eastern Ohio, as well as controls 113,000 net acres in Southwestern Pennsylvania and Northern West Virginia that contain the rights to the natural gas in Utica Shale; and owns rights to extract coalbed methane (CBM) in Virginia from approximately 268,000 net CBM acres, which cover a portion of its coal reserves in Central Appalachia. It also owns shallow oil and gas acreage position approximately 825,000 net acres in Illinois, Indiana, Kentucky, West Virginia, Pennsylvania, Virginia, and New York; various acres that have Upper Devonian potential; 116,000 net acres of Chattanooga Shale; and 380,000 net acres of Huron Shale potential in Kentucky, West Virginia, and Virginia, as well as provides midstream gas services. The Coal division engages in mining, preparation, and marketing of thermal coal primarily to power generators, and metallurgical coal to metal and coke producers. The company also provides energy services, including coal terminal services, water services, and land resource management services. CONSOL Energy Inc. was founded in 1864 and is headquartered in Canonsburg, Pennsylvania.

CVS Health Corporation (CVS) gained $1.44 to close the day at a new closing price of $80.35, a 1.82% increase in value from its previous closing price that moved the stock 15.95% above its 52 week low of $69.3. A total of 5.92M shares exchanged hands during the day compared with its three month average trading volume of 8.37M. The stock, which fluctuated between $78.97 and $80.45 during the day, currently situated -23.97% below its 52 week high. The stock is up by 4.68% in the past one month and down by -7.28% over the past three months. With a one year target estimate of $87.1 and RSI of 53.87, the stock still has upside potential, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

MannKind Corporation (MNKD) had a active trading with around 5.91M shares changing hands compared to its three month average trading volume of 4.99M. The stock traded between $0.6 and $0.675 before closing at the price of $0.63 with -0.83% change on the day. The Valencia California 91355 based company is currently trading 54% above its 52 week low of $0.41 and -71.81% below its 52 week high of $2.24. Both the RSI indicator and target price of 51.33 and $0 respectively, lead us to believe that it should be put on hold over the coming weeks.

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes patients in the United States. Its approved product is AFREZZA, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. MannKind Corporation has license and collaboration agreement with Sanofi-Aventis Deutschland GmbH for the development of AFREZZA. The company was founded in 1991 and is headquartered in Valencia, California.

 

Stocks in Review: Plug Power Inc. (PLUG), CVS Health Corporation (CVS), Texas Instruments Incorporated (TXN)

Plug Power Inc. (PLUG) traded within a range of $1.18 to $1.26 after opening the day at $1.25. The company has seen its stock decrease in value by -43.13% so far this year. The stock was down close to -1.64% on active volume in last trading session and closed at $1.2 per share. After the recent fall, the stock is currently holding -47.6% below its 52 week high of $2.28 and 1.69% above its 12-month low of $1.18. The shares are down by over -29.82% in the last three months, and the RSI indicator value of 33.33 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Plug Power Inc., an alternative energy technology provider, engages in the design, development, manufacture, and commercialization of fuel cell systems for the material handling and stationary power market in the United States. The company focuses on proton exchange membrane (PEM) fuel cell and fuel processing technologies, and fuel cell/battery hybrid technologies. Its product line includes GenKey, a turn-key solution for transitioning material handling vehicles to fuel cell power; GenDrive, a hydrogen fueled PEM fuel cell system that provides power to material handling vehicles; GenFuel, a hydrogen fueling delivery system; GenCare, which is an ongoing maintenance program for GenDrive fuel cells and GenFuel products; ReliOn, a stationary fuel cell solution that provides scalable and modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors; and GenFund, which offers financing solutions to customers. The company sells its products to businesses and government agencies through direct product sales force, original equipment manufacturers, and dealer networks. Plug Power Inc. was founded in 1997 and is headquartered in Latham, New York.

CVS Health Corporation (CVS) continued its downward trend with the stock declining -0.11% or $-0.09 to close the day at $78.91 on light trading volume of 4.33M shares, compared to its three month average trading volume of 8.45M. The Woonsocket Rhode Island 02895 based company has been underperforming the health care plans group over the past 52 weeks, with the stock losing -17.83%, compared to the industry which has advanced 5.14% over the same period. With RSI of 47.66, the stock should still continue to rise and get closer to its one year target estimate of $87.1, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Texas Instruments Incorporated (TXN) dropped $-1.18 to close the day at a new closing price of $72.97, a -1.59% decrease in value from its previous closing price that moved the stock 60.35% above its 52 week low of $46.73. A total of 4.31M shares exchanged hands during the day compared with its three month average trading volume of 5.16M. The stock, which fluctuated between $72.77 and $74.46 during the day, currently situated -3.03% below its 52 week high. The stock is down by -1.3% in the past one month and up by 4.74% over the past three months. With a one year target estimate of $74.89 and RSI of 50.91, the stock still has upside potential, making it a hold for now.

Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers worldwide. It operates through two segments, Analog and Embedded Processing. The Analog segment offers high volume analog and logic products for automotive safety devices, touch screen controllers, low voltage motor drivers, and integrated motor controllers; and power management products that include catalog and application-specific standard products to enhance the efficiency of powered devices using battery management solutions, portable power conversion devices, power supply controls, and point-of-load products. This segment also provides high performance analog products, such as high-speed data converters, amplifiers, sensors, high reliability products, interface products, and precision products; and silicon valley analog products, including power management, data converter, interface, and operational amplifier catalog analog products that are used in manufacturing various electronic systems. The Embedded Processing segment offers microcontroller products, which are systems with a processor core, memory, and peripherals to control a set of specific tasks for electronic equipment; processor products comprising digital signal and applications processors; and connectivity products consisting of electronic devices to connect and transfer data. The company also provides DLP products primarily used in projectors to create high-definition images; application-specific integrated circuits; calculators; and baseband products, as well as OMAP applications processors and connectivity products. It markets and sells its products through a direct sales force and distributors. Texas Instruments Incorporated was founded in 1930 and is headquartered in Dallas, Texas.

 

Stocks in the Spotlight: CVS Health Corporation (CVS), Mylan N.V. (MYL), Synchrony Financial (SYF)

CVS Health Corporation (CVS) had a light trading with around 3.58M shares changing hands compared to its three month average trading volume of 8.47M. The stock traded between $78.81 and $79.47 before closing at the price of $79 with -0.05% change on the day. The Woonsocket Rhode Island 02895 based company is currently trading 14.% above its 52 week low of $69.3 and -25.25% below its 52 week high of $106.67. Both the RSI indicator and target price of 48.11 and $87.1 respectively, lead us to believe that it should be put on hold over the coming weeks.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Mylan N.V. (MYL) managed to rebound with the stock climbing 0.46% or $0.17 to close the day at $37.38 on light trading volume of 3.53M shares, compared to its three month average trading volume of 6.55M. The Hatfield Hertfordshire EN6 1AG based company has been underperforming the drugs – generic group over the past 52 weeks, with the stock losing -31.56%, compared to the industry which has dropped -27.17% over the same period. With RSI of 53.18, the stock should still continue to rise and get closer to its one year target estimate of $50.89, making it a hold for now.

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, cream, or ointment forms, as well as active pharmaceutical ingredients (APIs). It is also involved in the development of APIs with non-infringing processes for internal use and to partner with manufacturers; and manufacture and sale of injectable products in antineoplastics, anti-infectives, anesthesia/pain management, and cardiovascular therapeutic areas. In addition, the company produces finished dosage form and oral solid dose products; and offers antiretroviral therapies to third parties. Further, it manufactures and sells branded specialty injectable and nebulized products comprising EpiPen Auto-Injector to treat severe allergic reactions; Perforomist Inhalation Solution, a formoterol fumarate inhalation solution for the maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disorder patients; and ULTIVA, an analgesic agent used during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. It sells generic pharmaceutical products to proprietary and ethical pharmaceutical wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies; and specialty pharmaceuticals to pharmaceutical wholesalers and distributors, pharmacies, and healthcare institutions. Mylan N.V. has a collaboration agreement with Momenta Pharmaceuticals, Inc. to develop, manufacture, and commercialize Momenta Pharmaceuticals, Inc.’s biosimilar candidates. The company was formerly known as New Moon B.V. Mylan N.V. was founded in 1961 and is based in Hertfordshire, the United Kingdom.

Synchrony Financial (SYF) shares were down in last trading by -0.41% to $36.09. It experienced lighter than average volume on day. The stock decreased in value by almost -2.72% over the past week and grew 6.78% in the past month. It is currently trading 9.92% above its 50 day moving average and 23.65% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -3.27% decrease in value from its one year high of $37.31. The RSI indicator value of 58.16, lead us to believe that it is a hold for now.

Synchrony Financial operates as a consumer financial services company in the United States. The company offers private label credit cards, dual cards, and small and medium-sized business credit products; and promotional financing for consumer purchases, such as private label credit cards and installment loans. It also provides promotional financing to consumers for elective healthcare procedures or services, such as dental, veterinary, cosmetic, vision, and audiology; debt cancellation products; and deposit products, including certificates of deposit, individual retirement, money market, and savings accounts, as well as accepts deposits through third-party securities brokerage firms. The company offers its credit products through programs established with a group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations, and healthcare service providers; and deposit products through multiple channels, including online, print, and radio advertising. Synchrony Financial was incorporated in 2003 and is headquartered in Stamford, Connecticut. Synchrony Financial operates independently of GE Consumer Finance, Inc. as of November 17, 2015.

 

3 Trending Stocks: Hanesbrands Inc. (HBI), CVS Health Corporation (CVS), Gulfport Energy Corp. (GPOR)

Hanesbrands Inc. (HBI) failed to extend gains with the stock declining -0.78% or $-0.17 to close the day at $21.53 on light trading volume of 3.37M shares, compared to its three month average trading volume of 5.95M. The Winston-Salem North Carolina 27105 based company has been underperforming the textile – apparel clothing group over the past 52 weeks, with the stock losing -25.46%, compared to the industry which has dropped -11.57% over the same period. With RSI of 29.02, the stock should still continue to rise and get closer to its one year target estimate of $32.33, making it a hold for now.

Hanesbrands Inc., a consumer goods company, designs, manufactures, sources, and sells various basic apparels for men, women, and children in the United States. The company operates through four segments: Innerwear, Activewear, Direct to Consumer, and International. It sells bras, panties, shapewears, hosiery, men’s underwear, children’s underwear, and socks; and other activewear, such as T-shirts, fleece, sport shirts, performance T-shirts and shorts, sports bras, and thermals, as well as licensed logo apparel in collegiate bookstores and other channels. The company licenses its Champion name for footwear and sports accessories. It provides its products primarily under the Maidenform, Bali, Playtex, Hanes, JMS/Just My Size, Lilyette, Wonderbra, Donna Karan, DKNY, Champion, Polo Ralph Lauren, L’eggs, Hanes Beefy-T, Gear for Sports, Duofold, DIM, Nur Die/Nur Der, Lovable, Shock Absorber, Abanderado, Zorba, Rinbros, Kendall, Sol y Oro, Fila, Bellinda, Edoo, and Track N Field brand names. The company markets its products through retailers, wholesalers, and third party embellishers, as well as directly to consumers. As of January 2, 2016, it operated 252 outlet stores in the United States; and Websites under the Hanes, One Hanes Place, JMS/Just My Size, Champion, and Maidenform names. The company also sells its products in Europe, Asia, Latin America, Canada, Australia, the Middle East, Africa, and the Caribbean. Hanesbrands Inc. was founded in 2005 and is headquartered in Winston-Salem, North Carolina.

CVS Health Corporation (CVS) fell -0.32% during last trading as the stock lost $-0.25 to finish the day at $79.04 with about 3.35M shares changing hands, compared to its three month average trading volume of 8.49M. The $84.41B market cap company, which fluctuated between $78.64 and $79.37 during the day, currently situated 14.05% above its 52 week low of $69.3 and -25.21% away from its one year high of $106.67. The RSI of 49.17 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Gulfport Energy Corp. (GPOR) saw its value decrease by -0.95% as the stock dropped $-0.21 to finish the day at a closing price of $21.98. The stock was higher in trading and has fluctuated between $21-$34.67 per share for the past year. The shares, which traded within a range of $21.78 to $22.25 during the day, are down by -19.87% in the past three months and down by -30.27% over the past six months. It is currently trading -13.7% below its 20 day moving average and -12.78% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $33.15 a share over the next twelve months. The current relative strength index (RSI) reading is 34.59. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Gulfport Energy Corp. engages in the acquisition, exploration, exploitation, and production of natural gas, natural gas liquids (NGLs), and crude oil in the United States. The company’s principal properties are located in the Utica Shale primarily in Eastern Ohio, along the Louisiana Gulf Coast in the West Cote Blanche Bay, and Hackberry fields. It also has interests in the Niobrara Formation of Northwestern Colorado; Bakken Formation; Alberta oil sands in Canada; and Phu Horm gas field in Thailand. As of December 31, 2015, the company had 1.7 Tcfe of proved reserves; and proved undeveloped reserves of 338 thousand barrels of oil, 907,184 million cubic feet of natural gas, and 4,826 thousand barrels of NGLs. Gulfport Energy Corp. is headquartered in Oklahoma City, Oklahoma.

 

Stocks Buzz: Office Depot, Inc. (ODP), OvaScience, Inc. (OVAS), CVS Health Corporation (CVS)

Office Depot, Inc. (ODP) managed to rebound with the stock climbing 0.86% or $0.04 to close the day at $4.7 on light trading volume of 2.79M shares, compared to its three month average trading volume of 8.89M. The Boca Raton Florida 33496 based company has been underperforming the specialty retail, other group over the past 52 weeks, with the stock losing -15.01%, compared to the industry which has advanced 7.02% over the same period. With RSI of 52.66, the stock should still continue to rise and get closer to its one year target estimate of $4.99, making it a hold for now.

Office Depot, Inc., together with its subsidiaries, supplies office products and services. It operates in three segments: North American Retail, North American Business Solutions, and International. The company sells office supplies, technology products and solutions, business machines and related supplies, facilities products, and office furniture. It also offers copy and print services. The company sells its products and services to consumers and businesses through office supply stores, a contract sales force, Internet sites, an outbound telephone account management sales force, direct marketing catalogs, and call centers, as well as participates under licensing and merchandise arrangements in Latin America, Europe, Israel, and Japan. As of December 26, 2015, it operated 1,564 stores in the United States, including Puerto Rico and the U.S. Virgin Islands; and 147 stores in France, South Korea, Sweden, New Zealand, and Australia. The company offers its products under various labels, including Office Depot, OfficeMax, Foray, Ativa, TUL, Realspace, WorkPro, Brenton Studio, Highmark, Grand & Toy, and Viking Office Products. Office Depot, Inc. was founded in 1986 and is headquartered in Boca Raton, Florida.

OvaScience, Inc. (OVAS) grew with the stock adding 4.48% or $0.06 to close at $1.4 on light trading volume of 2.77M compared its three months average trading volume of 687.81K. The Waltham Massachusetts 02451 based company operating under the Biotechnology industry has been trending down for the last 52 weeks, with the shares price now -86.72% down for the period and down by -85.67% so far this year. With price target of $9.5 and a 7.69% rebound from 52-week low, OvaScience, Inc. has plenty of upside potential, making it a hold with a view buy.

OvaScience, Inc., a fertility company, discovers, develops, and commercializes new fertility treatment options for women worldwide. The company’s patented technology is based on the discovery of egg precursor (EggPC) cells, which are immature egg cells found in the protective outer layer of a woman’s own ovaries. It engages in developing and commercializing various fertility treatment options designed to enhance egg health and revolutionize in vitro fertilization (IVF) consisting of AUGMENT to enhance the energy and health of the woman’s eggs by using mitochondria from a woman’s EggPC cells; OvaPrime treatment is used to replenish a woman’s egg reserve by transferring the EggPCs from woman’s own ovaries; OvaTure to produce mature fertilizable eggs from a woman’s own EggPC cells without the need for hormone injections; and OvaXon for the prevention of genetic disease and animal health. The company was formerly known as Ovastem, Inc. and changed its name to OvaScience, Inc. in May 2011. OvaScience, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.

CVS Health Corporation (CVS) managed to rebound with the stock climbing 0.44% or $0.35 to close the day at $79.14 on lower than average trading volume of 2.75M shares, compared to its three month average trading volume of 8.47M. The Woonsocket Rhode Island 02895 based company has been outperforming the health care plans companies by -11.6134% for last three months and its recent losses have pulled the stock down -17.59% YTD, versus the health care plans industry which is up 6.76% for the same period. The RSI of 48.13 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

Stocks Highlights: CenturyLink, Inc. (CTL), NRG Energy, Inc. (NRG), CVS Health Corporation (CVS)

CenturyLink, Inc. (CTL) had a light trading with around 5.98M shares changing hands compared to its three month average trading volume of 9.95M. The stock traded between $23.67 and $23.95 before closing at the price of $23.87 with 0.42% change on the day. The Monroe Louisiana 71203 based company is currently trading 17.66% above its 52 week low of $21.94 and -27.08% below its 52 week high of $33.45. Both the RSI indicator and target price of 42.03 and $28.08 respectively, lead us to believe that it should be put on hold over the coming weeks.

CenturyLink, Inc. provides various communications services to residential, business, wholesale, and governmental customers in the United States. It operates through two segments, Business and Consumer. The company offers high-speed Internet services, which allow customers to connect to the Internet through their existing telephone lines or fiber-optic cables; multi-protocol label switching, a data networking technology to support real-time voice and video; and private line services for the transmission of data between sites. It also provides Ethernet services, including point-to-point and multi-point equipment configurations that facilitate data transmissions across metropolitan areas and wide area networks (WAN); colocation services that enable its customers to install their own information technology (IT) equipment; and managed hosting services comprising cloud and traditional computing, application management, back-up, storage, and other services. In addition, the company offers video entertainment services and satellite digital television; Voice over Internet Protocol, a real-time, two-way voice communication service; and managed services that consist of network, hosting, cloud, and IT services. Further, it provides local calling, long-distance voice, integrated services digital network, WAN, and switched access services; and data integration, which includes the sale of telecommunications equipment and providing network management, installation, and maintenance of data equipment, and the building of proprietary fiber-optic broadband networks. Additionally, the company leases and subleases space in its office buildings, warehouses, and other properties. As of December 31, 2015, it served approximately 6 million high-speed Internet subscribers and 285 thousand television subscribers; and operated 59 data centers in North America, Europe, and Asia. CenturyLink, Inc. was founded in 1968 and is headquartered in Monroe, Louisiana.

NRG Energy, Inc. (NRG) continued its downward trend with the stock declining -1.94% or $-0.24 to close the day at $12.13 on light trading volume of 5.89M shares, compared to its three month average trading volume of 6.25M. The Princeton New Jersey 08540 based company has been outperforming the diversified utilities group over the past 52 weeks, with the stock gaining 7.43%, compared to the industry which has advanced 19.28% over the same period. With RSI of 52.26, the stock should still continue to rise and get closer to its one year target estimate of $15.93, making it a hold for now.

NRG Energy, Inc., together with its subsidiaries, operates as a power company. The company provides electricity; system power, distributed generation, solar and wind products, backup generation, storage and distributed solar, demand response, energy efficiency, electric vehicle charging stations, and on-site energy solutions; carbon management and specialty services; and various energy services, such as operations, maintenance, technical, development, and asset management services. It owns and operates approximately 50,000 megawatts of generation. The company also offers retail energy, rooftop solar, portable solar, and battery products home services; and various bundled products, which combine energy with protection products, energy efficiency, and renewable energy solutions, as well as offers installation and contract management services for residential solar customers. As of December 31, 2015, it served approximately 2.77 million recurring and 624,000 discrete customers. In addition, the company owns, operates, and develops solar and wind power projects; develops, constructs, and finances a range of solutions for utilities, schools, municipalities, and commercial markets; and trades in electric power, natural gas, and related commodity and financial products, including forwards, futures, options, and swaps. As of December 31, 2015, it operated 90 active fossil fuel and nuclear plants, 16 utility scale solar facilities, and 36 wind farms and multiple distributed solar facilities. Further, the company transacts in and trades fuel and transportation services; directly sells energy, services, and products and services to retail customers under the NRG, Reliant, and other names; and provides steam, hot water, and chilled water, as well as electricity to commercial businesses, universities, hospitals, and governmental units. NRG Energy, Inc. was founded in 1989 and is headquartered in Princeton, New Jersey.

CVS Health Corporation (CVS) shares were down in last trading by -1.33% to $78.79. It experienced lighter than average volume on day. The stock increased in value by almost 0.64% over the past week and grew 7.07% in the past month. It is currently trading -1.89% below its 50 day moving average and -14.55% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -25.44% decrease in value from its one year high of $106.67. The RSI indicator value of 47.13, lead us to believe that it is a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

Stocks Highlights: Sunoco Logistics Partners L.P. (SXL), Conatus Pharmaceuticals Inc. (CNAT), CVS Health Corporation (CVS)

Sunoco Logistics Partners L.P. (SXL) had a active trading with around 5.87M shares changing hands compared to its three month average trading volume of 2.56M. The stock traded between $23.55 and $23.99 before closing at the price of $23.96 with 1.31% change on the day. The Newtown Square Pennsylvania 19073 based company is currently trading 67.66% above its 52 week low of $15.43 and -22.29% below its 52 week high of $31.49. Both the RSI indicator and target price of 48.73 and $0 respectively, lead us to believe that it should be put on hold over the coming weeks.

Sunoco Logistics Partners L.P. transports, terminals, and stores crude oil, refined products, and natural gas liquids (NGLs). Its Crude Oil segment provides transportation, terminalling, and acquisition and marketing services to crude oil markets in the southwest, Midwest, and northeastern United States. It contains approximately 5,900 miles of crude oil trunk and gathering pipelines; and has interests in 3 crude oil pipelines. The segment also operates with an aggregate storage capacity of approximately 28 million barrels, including approximately 24 million barrels in Nederland, Texas; and approximately 3 million barrels in Pennsylvania. The Natural Gas Liquids segment offers transportation, storing, and acquisition and marketing activities that include pipelines, storage and blending facilities, and strategic off-take locations that provide access to multiple NGLs markets. It contains approximately 900 miles of NGLs pipelines located in the northeast and southwest United States. The segment operates with storage capacity of approximately 5 million barrels, including approximately 1 million barrels in Texas; and 3 million barrels in Pennsylvania. It also engages in blending activities. The Refined Products segment provides transportation and terminalling services in the northeast, Midwest, and southeast United States. It operates approximately 1,800 miles of refined products pipelines; 40 active refined products marketing terminals; and storage capacity of approximately 8 million barrels. Sunoco Partners LLC serves as the general partner of the company. The company was founded in 2001 and is based in Newtown Square, Pennsylvania.

Conatus Pharmaceuticals Inc. (CNAT) failed to extend gains with the stock declining -8.67% or $-0.41 to close the day at $4.32 on light trading volume of 5.82M shares, compared to its three month average trading volume of 965.27K. The San Diego California 92127 based company has been outperforming the biotechnology group over the past 52 weeks, with the stock gaining 44.97%, compared to the industry which has dropped -10.88% over the same period. With RSI of 79.83, the stock should still continue to rise and get closer to its one year target estimate of $9.67, making it a hold for now.

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sustained viral response, non-alcoholic steatohepatitis, and nonalcoholic fatty liver disease and raised transaminases, as well as for the treatment of patients with severe alcoholic hepatitis. The company was founded in 2005 and is headquartered in San Diego, California.

CVS Health Corporation (CVS) shares were up in last trading by 0.01% to $79.85. It experienced lighter than average volume on day. The stock increased in value by almost 1.13% over the past week and grew 7.61% in the past month. It is currently trading -0.72% below its 50 day moving average and -13.49% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -24.44% decrease in value from its one year high of $106.67. The RSI indicator value of 51.56, lead us to believe that it is a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

Equities Trend Analysis: CVS Health Corporation (CVS), Wal-Mart Stores, Inc. (WMT), Staples, Inc. (SPLS)

CVS Health Corporation (CVS) retreated with the stock falling -0.11% or $-0.09 to close at $79.84 on light trading volume of 6.11M compared its three months average trading volume of 8.5M. The Woonsocket Rhode Island 02895 based company operating under the Health Care Plans industry has been trending down for the last 52 weeks, with the shares price now -15.28% down for the period and down by -16.86% so far this year. With price target of $86.71 and a 15.21% rebound from 52-week low, CVS Health Corporation has plenty of upside potential, making it a hold with a view buy.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Wal-Mart Stores, Inc. (WMT) had a light trading with around 6.1M shares changing hands compared to its three month average trading volume of 8.71M. The stock traded between $71.51 and $71.93 before closing at the price of $71.82 with 0.34% change on the day. The Bentonville Arkansas 72716 based company is currently trading 25.97% above its 52 week low of $60.2 and -3.8% below its 52 week high of $75.19. Both the RSI indicator and target price of  and $74.43 respectively, lead us to believe that it could rise over the coming weeks.

Wal-Mart Stores, Inc. operates retail stores in various formats worldwide. It operates through three segments: Walmart U.S., Walmart International, and Sam’s Club. The company operates discount stores, supermarkets, supercenters, hypermarkets, warehouse clubs, cash and carry stores, home improvement stores, specialty electronics stores, apparel stores, drug stores, convenience stores, and membership-only warehouse clubs; and retail Websites, such as walmart.com and samsclub.com. It offers grocery products, including meat, produce, natural and organics, deli and bakery, dairy, frozen foods, alcoholic and nonalcoholic beverages, floral and dry grocery, as well as consumables, such as health and beauty aids, baby products, household chemicals, paper goods, and pet supplies; and health and wellness products, which include pharmacy, optical services, clinical services, over-the-counter drugs, and other medical products. The company also provides electronics, toys, cameras and supplies, photo processing services, cellular phones, cellular service plan contracts and prepaid service, movies, music, video games, and books; stationery, automotive, hardware and paint, and sporting goods, as well as fabrics, crafts, and seasonal merchandise; apparel for women, girls, men, boys, and infants, as well as shoes, jewelry, and accessories; and home furnishings, housewares and small appliances, bedding, home decor, outdoor living, and horticulture products. The company also provides fuel and financial services and related products, including money orders, prepaid cards, wire transfers, money transfers, check cashing, and bill payment. In addition, it offers brand name merchandise, including hardgoods, softgoods, and selected private-label items, such as Member’s Mark. As of June 20, 2016, it operated 11,527 stores under 63 banners in 28 countries and e-commerce Websites in 11 countries. Wal-Mart Stores, Inc. was founded in 1945 and is headquartered in Bentonville, Arkansas.

Staples, Inc. (SPLS) saw its value increase by 0.72% as the stock gained $0.07 to finish the day at a closing price of $9.84. The stock was lighter in trading and has fluctuated between $7.24-$11.37 per share for the past year. The shares, which traded within a range of $9.8 to $10.06 during the day, are up by 17.73% in the past three months and up by 16.26% over the past six months. It is currently trading 1.15% above its 20 day moving average and 14.84% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $9.75 a share over the next twelve months. The current relative strength index (RSI) reading is 68.66.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Staples, Inc., together with its subsidiaries, operates office products superstores. It operates in three segments: North American Stores & Online, North American Commercial, and International Operations. The company offers a range of office supplies, business technology products, facility and breakroom supplies, computers and mobility products, and office furniture under the Staples, Quill, and other proprietary brands. It also provides copy and print services, as well as technology services. The company sells and delivers office products and services directly to businesses and consumers through its Staples.com and Staples.ca, and Quill.com Websites, as well as through retail stores, and Internet and direct mail catalogs. As of January 30, 2016, it operated approximately 1,907 retail stores; and 104 distribution and fulfillment centers in the United States and internationally. The company was founded in 1985 and is based in Framingham, Massachusetts.

 

Stocks In Queue: Altria Group, Inc. (MO), CVS Health Corporation (CVS), Novavax, Inc. (NVAX)

Altria Group, Inc. (MO) climbed 1.07% during last trading as the stock added $0.72 to finish the day at $67.76 with about 6.87M shares changing hands, compared to its three month average trading volume of 6.68M. The $132.27B market cap company, which fluctuated between $67.21 and $67.86 during the day, currently situated 24.14% above its 52 week low of $56.15 and -2.49% away from its one year high of $70.14. The RSI of 68.2 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, smokeless products, and wine in the United States. It offers cigarettes primarily under the Marlboro brand; cigars principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen and Skoal, Red Seal and Husky, and Marlboro Snus brand names. The company also produces and sells varietal and blended table wines, and sparkling wines under the Chateau Ste. Michelle, Columbia Crest, and 14 Hands names; and imports and markets Antinori, Torres, and Villa Maria Estate wines, as well as Champagne Nicolas Feuillatte in the United States. In addition, it provides finance leasing services primarily in aircraft, railcar, electric power, real estate, and manufacturing industries. The company sells its tobacco products primarily to wholesalers, including distributors; large retail organizations, such as chain stores; and the armed services. Altria Group, Inc. was founded in 1919 and is headquartered in Richmond, Virginia.

CVS Health Corporation (CVS) gained $0.37 to close the day at a new closing price of $79.93, a 0.47% increase in value from its previous closing price that moved the stock 15.34% above its 52 week low of $69.3. A total of 6.92M shares exchanged hands during the day compared with its three month average trading volume of 8.51M. The stock, which fluctuated between $79.27 and $80.22 during the day, currently situated -24.37% below its 52 week high. The stock is up by 7.62% in the past one month and down by -10.74% over the past three months. With a one year target estimate of $86.71 and RSI of 53.11, the stock still has upside potential, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Novavax, Inc. (NVAX) had a active trading with around 6.89M shares changing hands compared to its three month average trading volume of 16.12M. The stock traded between $1.37 and $1.47 before closing at the price of $1.4 with 0% change on the day. The Gaithersburg Maryland 20878 based company is currently trading 20.69% above its 52 week low of $1.16 and -84.36% below its 52 week high of $8.88. Both the RSI indicator and target price of 51.64 and $3.29 respectively, lead us to believe that it should be put on hold over the coming weeks.

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization that are in Phase III clinical trials, as well as pediatric RSV candidate, which is in Phase I clinical trial; seasonal quadrivalent influenza and pandemic H7N9 vaccines, which are in Phase II clinical trials; vaccine candidate against Ebola Virus that is Phase I clinical trial, as well as combination respiratory vaccine candidate and seasonal influenza vaccine candidate that is in pre-clinical trial; and rabies G protein vaccine candidate, which is in Phase I/II clinical trial. The company also has pre-clinical stage programs for various infectious diseases, including the Middle East respiratory syndrome coronavirus; and develops technology for the production of immune stimulating saponin-based adjuvants. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.

Stocks Trend Analysis: CVS Health Corporation (CVS), General Growth Properties, Inc (GGP), D.R. Horton, Inc. (DHI)

CVS Health Corporation (CVS) managed to rebound with the stock climbing 1.62% or $1.27 to close the day at $79.56 on light trading volume of 11.55M shares, compared to its three month average trading volume of 8.45M. The Woonsocket Rhode Island 02895 based company has been underperforming the health care plans group over the past 52 weeks, with the stock losing -14.48%, compared to the industry which has advanced 7.91% over the same period. With RSI of 52.95, the stock should still continue to rise and get closer to its one year target estimate of $86.71, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

General Growth Properties, Inc (GGP) grew with the stock adding 1.28% or $0.33 to close at $26.09 on light trading volume of 11.52M compared its three months average trading volume of 4.24M. The Chicago Illinois 60606 based company operating under the REIT – Retail industry has been trending down for the last 52 weeks, with the shares price now -2.76% down for the period and down by -4.12% so far this year. With price target of $31.56 and a 9.21% rebound from 52-week low, General Growth Properties, Inc has plenty of upside potential, making it a hold with a view buy.

General Growth Properties, Inc is an equity real estate investment trust. The firm invests in the real estate markets of the United States. It engages in owning, managing, leasing, and redeveloping high-quality regional malls. General Growth Properties, Inc is based in Chicago, Illinois.

D.R. Horton, Inc. (DHI) managed to rebound with the stock climbing 0.54% or $0.15 to close the day at $28.04 on lower than average trading volume of 11.5M shares, compared to its three month average trading volume of 4.55M. The Fort Worth Texas 76102 based company has been outperforming the residential construction companies by -7.6217% for last three months and its recent losses have pulled the stock down -11.42% YTD, versus the residential construction industry which is down -1.96% for the same period. The RSI of 45.6 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

D.R. Horton, Inc. operates as a homebuilding company. It engages in the acquisition and development of land; and construction and sale of homes in 26 states and 78 markets in the United States under the names of D.R. Horton, America’s Builder, Express Homes, Emerald Homes, Regent Homes, Crown Communities, and Pacific Ridge Homes. The company constructs and sells single-family detached homes; and attached homes, such as town homes, duplexes, triplexes, and condominiums. It is also involved in the origination and sale of mortgages; and provision of title insurance policies, and examination and closing services. The company primarily serves title insurance agents, homebuyers, and homebuilding customers. D.R. Horton, Inc. was founded in 1978 and is headquartered in Fort Worth, Texas.